Guoqiang Fu, Zhujun Wang, Binfen Rao, Jie Liu, Hui Ouyang
{"title":"Pannexin-1 (PANX1) in Metabolic Diseases: Structural Basis, Molecular Mechanisms, and Pharmacological Significance.","authors":"Guoqiang Fu, Zhujun Wang, Binfen Rao, Jie Liu, Hui Ouyang","doi":"10.1016/j.cellsig.2026.112993","DOIUrl":"10.1016/j.cellsig.2026.112993","url":null,"abstract":"<p><p>Metabolic diseases, including obesity, type 2 diabetes mellitus (T2DM), metabolic dysfunction-associated steatotic liver disease (MASLD), atherosclerosis (AS), and diabetes-related complications, are characterized by disrupted glucose and lipid metabolism, chronic inflammation, oxidative stress, and progressive tissue dysfunction. Pannexin-1 (PANX1), a large-pore membrane channel that mediates regulated ATP release, has emerged as an important interface between metabolic stress and extracellular purinergic signaling. PANX1 influences metabolic homeostasis through ATP-dependent and broader signaling mechanisms that regulate insulin action and secretion, hepatic glucose and lipid metabolism, autophagy, vascular function, inflammatory responses, and regulated cell death. Its effects are highly context dependent. PANX1 can support metabolic homeostasis in adipocytes, pancreatic β cells, hepatocytes, and selected vascular cell populations, whereas sustained or dysregulated PANX1 signaling may promote inflammation, vascular dysfunction, ferroptosis, and pyroptosis under metabolic stress. These divergent actions are shaped by cellular origin, disease stage, and the local metabolic environment. This review summarizes current understanding of PANX1 structure, channel gating, and regulatory mechanisms and integrates predominantly preclinical evidence for its involvement in metabolic homeostasis and related diseases. We further examine the interactions of PANX1 with purinergic signaling, inflammation, oxidative stress, organelle homeostasis, and regulated cell death, together with current pharmacological strategies targeting PANX1. Although most available PANX1 modulators remain primarily mechanistic tools and lack direct evidence of therapeutic efficacy in metabolic disease models, these findings provide a foundation for the future development and evaluation of more selective PANX1-targeted interventions.</p>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":" ","pages":"112993"},"PeriodicalIF":4.7,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zihan Wang, Wenbo Wang, Lin Wei, Haocheng Wang, Lina Yang
{"title":"The role of USP38 in cellular stress adaptation: Context-dependent ubiquitin chain editing.","authors":"Zihan Wang, Wenbo Wang, Lin Wei, Haocheng Wang, Lina Yang","doi":"10.1016/j.cellsig.2026.112983","DOIUrl":"10.1016/j.cellsig.2026.112983","url":null,"abstract":"<p><p>Ubiquitin-specific protease 38 (USP38) edits ubiquitin chains on specific substrates, generating distinct biological outputs under different stress conditions, and thus functions as a context-dependent ubiquitin chain-editing enzyme. USP38 has recently been implicated in innate immunity, inflammatory transcription, fibrotic remodeling, hypoxic adaptation, lipid metabolism, genome maintenance, and tumor progression. However, available studies are scattered across distinct substrates and disease models, potentially leading to an oversimplified view of USP38 as merely a protein-stabilizing factor. Accordingly, this review integrates the molecular functions of USP38 from substrate and ubiquitin-chain-type-dependent perspectives and proposes that USP38 can be viewed as a context-dependent ubiquitin-chain modifier. By removing or remodeling specific ubiquitin chains, USP38 can alter substrate stability, regulate signaling duration, and reset the threshold of cellular stress responses. USP38 acts on diverse substrates, and distinct USP38- substrate axes can translate chain-type-specific deubiquitination into diverse biological outcomes, including inflammatory and fibrotic responses, hypoxic and metabolic adaptation, ferroptosis-associated vulnerabilities, DNA repair, and therapeutic responses, thereby establishing mechanistic links among these processes. Available evidence indicates that USP38-mediated deubiquitination is determined by the linkage type and modification site removed from a given substrate, with functional outcomes ranging from protein stabilization and altered enzymatic activity to subsequent substrate degradation. This review further integrates substrate engagement and complex recruitment, regulatory modifications of USP38, cell type, and stimulus-dependent interaction dynamics to explain how these molecular changes translate into distinct biological outcomes under diverse stress conditions. We also separate well-validated substrate mechanisms from integrative models that remain to be tested. Therefore, USP38-dependent stress-adaptation networks may create exploitable therapeutic vulnerabilities in specific tumors and chronic inflammatory diseases, although systemic inhibition of USP38 may also impair normal tissue homeostasis. Future studies should advance from validating single substrates to exploring chain typ -resolved ubiquitinomics, mapping stress-conditioned interactomes, and developing biomarker - guided, context-specific therapeutic strategies.</p>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":" ","pages":"112983"},"PeriodicalIF":4.7,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hengmei Shi, Senhui Zhang, Huyang Hou, Tong Li, Danni He, Deshuo Jiang, Xin Cheng, Le Ma, Xuan Lin, Yangkaiyuan Liu, Zheng Ding, Hongjie Ruan, Ziyi Fu, Xiaoyan Shi
{"title":"An anti-invasion endogenous tRNA-derived small RNA (3'-tRF<sup>AlaAGC</sup>) alleviates endometriosis by suppressing MCCC1 mediated EMT.","authors":"Hengmei Shi, Senhui Zhang, Huyang Hou, Tong Li, Danni He, Deshuo Jiang, Xin Cheng, Le Ma, Xuan Lin, Yangkaiyuan Liu, Zheng Ding, Hongjie Ruan, Ziyi Fu, Xiaoyan Shi","doi":"10.1016/j.cellsig.2026.112990","DOIUrl":"10.1016/j.cellsig.2026.112990","url":null,"abstract":"<p><p>Endometriosis is an invasive gynecological disorder, characterized by occult ectopic endometrial growth. Nascent endogenous tRNA-derived fragments occur across various disease, yet its pathology mechanistic pathways in endometriosis remain poorly defined. Downregulated 3'-tRF<sup>AlaAGC</sup> validated from endometrial lesions and serum was demonstrated to suppress the invasion of endometriosis. Indeed, we identified that nuclear translocation of p65 mediated by MCCC1 protein was attenuated due to the occurrence of 3'-tRF<sup>AlaAGC</sup>-MCCC1 compound relying on the 383-494aa of MCCC1, a unique binding site where 3'-tRF<sup>AlaAGC</sup> directly bond to MCCC1. Hence, the activation of NF-κB pathway was inhibited, hindering the epithelial-mesenchymal transition related to the progression of endometriosis. Moreover, 3'-tRF<sup>AlaAGC</sup> alleviated lesion burden in endometriosis mice, and the precious predictive efficiency in serum through the Machine learning. Understanding the 3'-tRF<sup>AlaAGC</sup> provides a critical opportunity to dissect the mechanisms driving endometriosis progression, opening new avenues to diagnose and halt endometriosis in its tracks.</p>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":" ","pages":"112990"},"PeriodicalIF":4.7,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Enterochromaffin cell-derived 5-HT contributes to dexamethasone protection against cisplatin-induced nausea-related responses.","authors":"Dongping Lyu, Shichen Fu, Junyan Qu, Jinghui Zhang, Wenxin Zhang, Xia Wang, Lixiang Li, Yanqing Li, Xiuli Zuo","doi":"10.1016/j.cellsig.2026.112991","DOIUrl":"10.1016/j.cellsig.2026.112991","url":null,"abstract":"<p><p>Enterochromaffin (EC) cell-derived 5-hydroxytryptamine (5-HT) is a major peripheral mediator of cisplatin-induced nausea and emesis. Dexamethasone is a cornerstone of antiemetic prophylaxis, yet whether dexamethasone regulates small-intestinal enterochromaffin-cell 5-HT output during cisplatin challenge and thereby influences downstream gut-brain responses remains unknown. We investigated whether dexamethasone suppresses EC-derived 5-HT and whether this epithelial mechanism contributes to protection against cisplatin-induced nausea-related responses. Three complementary approaches were used: (i) human gastrointestinal single-cell data and biopsy specimens to assess glucocorticoid receptor expression; (ii) primary mouse small-intestinal organoids to examine basal, cisplatin-evoked, and interleukin-33-evoked 5-HT responses; and (iii) cisplatin-treated mice to evaluate conditioned flavor aversion, pica, food and water intake, body-weight change, and nucleus of the solitary tract c-Fos activation. Intestinal epithelial Tph1-deficient mice and the 5-HT precursor 5-hydroxytryptophan were used for functional validation. Glucocorticoid receptor was broadly expressed in gastrointestinal EC cells. In organoids, dexamethasone reduced Tph1 expression, TPH1 protein abundance, and extracellular 5-HT without decreasing EC-cell abundance, and suppressed cisplatin- and interleukin-33-evoked 5-HT responses. RU486 counteracted dexamethasone-induced reductions in Tph1 expression and extracellular 5-HT during cisplatin challenge. In vivo, dexamethasone attenuated cisplatin-induced intestinal Tph1 expression, tissue 5-HT, nausea-related behavioral responses, and brainstem c-Fos activation, whereas RU486 weakened these effects. Dexamethasone did not significantly improve the measured outcomes in intestinal epithelial Tph1-deficient mice, whereas 5-hydroxytryptophan counteracted its behavioral and brainstem effects in wild-type mice. Together, these findings support a contribution of intestinal EC-derived 5-HT to dexamethasone-associated protection against cisplatin-induced nausea-related responses in mice.</p>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":" ","pages":"112991"},"PeriodicalIF":4.7,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ping Huang, Rong Yin, Weina Xu, Shenggeng Wang, Hongmei Yong, Tian Yang
{"title":"Corrigendum to \"The role of IL-6 in tumor immunity and related research progress\" [Cell. Signal. 143 (2026) 112460].","authors":"Ping Huang, Rong Yin, Weina Xu, Shenggeng Wang, Hongmei Yong, Tian Yang","doi":"10.1016/j.cellsig.2026.112977","DOIUrl":"https://doi.org/10.1016/j.cellsig.2026.112977","url":null,"abstract":"","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":" ","pages":"112977"},"PeriodicalIF":4.7,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}